Mazzone, Luigi <br/><br/>
Lower IQ is associated with decreased clinical response to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.  [electronic resource] 

 -  CNS drugs  Jun 2011 
 - 503-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-1934 
<br/><br/><label>Standard No.: </label>10.2165/11590450-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adrenergic Uptake Inhibitors--administration & dosage<br/>Atomoxetine Hydrochloride<br/>Attention Deficit Disorder with Hyperactivity--diagnosis<br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Intelligence--classification<br/>Male<br/>Patient Dropouts--statistics & numerical data<br/>Propylamines--administration & dosage<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Treatment Outcome